Global Alpha Thalassemia Market Insights and Forecast to 2028

  • Report ID:209567
  • Industry Name: Medical Care
  • Publishing Date: May-22
  • No. of Pages: 73
                              
Alpha Thalassemia market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Alpha Thalassemia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Iron Chelating Drugs Gene Therapy Segment by Application Hospitals Private Clinics Other By Company Bluebird Bio Novartis Kiadis Pharma Acceleron Pharma By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Alpha Thalassemia Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Iron Chelating Drugs 1.2.3 Gene Therapy 1.3 Market by Application 1.3.1 Global Alpha Thalassemia Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Private Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Alpha Thalassemia Market Perspective (2017-2028) 2.2 Alpha Thalassemia Growth Trends by Region 2.2.1 Alpha Thalassemia Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Alpha Thalassemia Historic Market Size by Region (2017-2022) 2.2.3 Alpha Thalassemia Forecasted Market Size by Region (2023-2028) 2.3 Alpha Thalassemia Market Dynamics 2.3.1 Alpha Thalassemia Industry Trends 2.3.2 Alpha Thalassemia Market Drivers 2.3.3 Alpha Thalassemia Market Challenges 2.3.4 Alpha Thalassemia Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Alpha Thalassemia Players by Revenue 3.1.1 Global Top Alpha Thalassemia Players by Revenue (2017-2022) 3.1.2 Global Alpha Thalassemia Revenue Market Share by Players (2017-2022) 3.2 Global Alpha Thalassemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Alpha Thalassemia Revenue 3.4 Global Alpha Thalassemia Market Concentration Ratio 3.4.1 Global Alpha Thalassemia Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Alpha Thalassemia Revenue in 2021 3.5 Alpha Thalassemia Key Players Head office and Area Served 3.6 Key Players Alpha Thalassemia Product Solution and Service 3.7 Date of Enter into Alpha Thalassemia Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Alpha Thalassemia Breakdown Data by Type 4.1 Global Alpha Thalassemia Historic Market Size by Type (2017-2022) 4.2 Global Alpha Thalassemia Forecasted Market Size by Type (2023-2028) 5 Alpha Thalassemia Breakdown Data by Application 5.1 Global Alpha Thalassemia Historic Market Size by Application (2017-2022) 5.2 Global Alpha Thalassemia Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Alpha Thalassemia Market Size (2017-2028) 6.2 North America Alpha Thalassemia Market Size by Type 6.2.1 North America Alpha Thalassemia Market Size by Type (2017-2022) 6.2.2 North America Alpha Thalassemia Market Size by Type (2023-2028) 6.2.3 North America Alpha Thalassemia Market Share by Type (2017-2028) 6.3 North America Alpha Thalassemia Market Size by Application 6.3.1 North America Alpha Thalassemia Market Size by Application (2017-2022) 6.3.2 North America Alpha Thalassemia Market Size by Application (2023-2028) 6.3.3 North America Alpha Thalassemia Market Share by Application (2017-2028) 6.4 North America Alpha Thalassemia Market Size by Country 6.4.1 North America Alpha Thalassemia Market Size by Country (2017-2022) 6.4.2 North America Alpha Thalassemia Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Alpha Thalassemia Market Size (2017-2028) 7.2 Europe Alpha Thalassemia Market Size by Type 7.2.1 Europe Alpha Thalassemia Market Size by Type (2017-2022) 7.2.2 Europe Alpha Thalassemia Market Size by Type (2023-2028) 7.2.3 Europe Alpha Thalassemia Market Share by Type (2017-2028) 7.3 Europe Alpha Thalassemia Market Size by Application 7.3.1 Europe Alpha Thalassemia Market Size by Application (2017-2022) 7.3.2 Europe Alpha Thalassemia Market Size by Application (2023-2028) 7.3.3 Europe Alpha Thalassemia Market Share by Application (2017-2028) 7.4 Europe Alpha Thalassemia Market Size by Country 7.4.1 Europe Alpha Thalassemia Market Size by Country (2017-2022) 7.4.2 Europe Alpha Thalassemia Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Alpha Thalassemia Market Size (2017-2028) 8.2 Asia-Pacific Alpha Thalassemia Market Size by Type 8.2.1 Asia-Pacific Alpha Thalassemia Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Alpha Thalassemia Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Alpha Thalassemia Market Share by Type (2017-2028) 8.3 Asia-Pacific Alpha Thalassemia Market Size by Application 8.3.1 Asia-Pacific Alpha Thalassemia Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Alpha Thalassemia Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Alpha Thalassemia Market Share by Application (2017-2028) 8.4 Asia-Pacific Alpha Thalassemia Market Size by Region 8.4.1 Asia-Pacific Alpha Thalassemia Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Alpha Thalassemia Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Alpha Thalassemia Market Size (2017-2028) 9.2 Latin America Alpha Thalassemia Market Size by Type 9.2.1 Latin America Alpha Thalassemia Market Size by Type (2017-2022) 9.2.2 Latin America Alpha Thalassemia Market Size by Type (2023-2028) 9.2.3 Latin America Alpha Thalassemia Market Share by Type (2017-2028) 9.3 Latin America Alpha Thalassemia Market Size by Application 9.3.1 Latin America Alpha Thalassemia Market Size by Application (2017-2022) 9.3.2 Latin America Alpha Thalassemia Market Size by Application (2023-2028) 9.3.3 Latin America Alpha Thalassemia Market Share by Application (2017-2028) 9.4 Latin America Alpha Thalassemia Market Size by Country 9.4.1 Latin America Alpha Thalassemia Market Size by Country (2017-2022) 9.4.2 Latin America Alpha Thalassemia Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Alpha Thalassemia Market Size (2017-2028) 10.2 Middle East & Africa Alpha Thalassemia Market Size by Type 10.2.1 Middle East & Africa Alpha Thalassemia Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Alpha Thalassemia Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Alpha Thalassemia Market Share by Type (2017-2028) 10.3 Middle East & Africa Alpha Thalassemia Market Size by Application 10.3.1 Middle East & Africa Alpha Thalassemia Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Alpha Thalassemia Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Alpha Thalassemia Market Share by Application (2017-2028) 10.4 Middle East & Africa Alpha Thalassemia Market Size by Country 10.4.1 Middle East & Africa Alpha Thalassemia Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Alpha Thalassemia Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bluebird Bio 11.1.1 Bluebird Bio Company Details 11.1.2 Bluebird Bio Business Overview 11.1.3 Bluebird Bio Alpha Thalassemia Introduction 11.1.4 Bluebird Bio Revenue in Alpha Thalassemia Business (2017-2022) 11.1.5 Bluebird Bio Recent Developments 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Alpha Thalassemia Introduction 11.2.4 Novartis Revenue in Alpha Thalassemia Business (2017-2022) 11.2.5 Novartis Recent Developments 11.3 Kiadis Pharma 11.3.1 Kiadis Pharma Company Details 11.3.2 Kiadis Pharma Business Overview 11.3.3 Kiadis Pharma Alpha Thalassemia Introduction 11.3.4 Kiadis Pharma Revenue in Alpha Thalassemia Business (2017-2022) 11.3.5 Kiadis Pharma Recent Developments 11.4 Acceleron Pharma 11.4.1 Acceleron Pharma Company Details 11.4.2 Acceleron Pharma Business Overview 11.4.3 Acceleron Pharma Alpha Thalassemia Introduction 11.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Business (2017-2022) 11.4.5 Acceleron Pharma Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Alpha Thalassemia Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Iron Chelating Drugs Table 3. Key Players of Gene Therapy Table 4. Global Alpha Thalassemia Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Alpha Thalassemia Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Alpha Thalassemia Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Alpha Thalassemia Market Share by Region (2017-2022) Table 8. Global Alpha Thalassemia Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Alpha Thalassemia Market Share by Region (2023-2028) Table 10. Alpha Thalassemia Market Trends Table 11. Alpha Thalassemia Market Drivers Table 12. Alpha Thalassemia Market Challenges Table 13. Alpha Thalassemia Market Restraints Table 14. Global Alpha Thalassemia Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Alpha Thalassemia Revenue Share by Players (2017-2022) Table 16. Global Top Alpha Thalassemia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Thalassemia as of 2021) Table 17. Ranking of Global Top Alpha Thalassemia Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Alpha Thalassemia Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Alpha Thalassemia Product Solution and Service Table 21. Date of Enter into Alpha Thalassemia Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Alpha Thalassemia Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Alpha Thalassemia Revenue Market Share by Type (2017-2022) Table 25. Global Alpha Thalassemia Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Alpha Thalassemia Revenue Market Share by Type (2023-2028) Table 27. Global Alpha Thalassemia Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Alpha Thalassemia Revenue Share by Application (2017-2022) Table 29. Global Alpha Thalassemia Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Alpha Thalassemia Revenue Share by Application (2023-2028) Table 31. North America Alpha Thalassemia Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Alpha Thalassemia Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Alpha Thalassemia Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Alpha Thalassemia Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Alpha Thalassemia Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Alpha Thalassemia Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Alpha Thalassemia Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Alpha Thalassemia Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Alpha Thalassemia Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Alpha Thalassemia Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Alpha Thalassemia Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Alpha Thalassemia Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Alpha Thalassemia Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Alpha Thalassemia Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Alpha Thalassemia Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Alpha Thalassemia Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Alpha Thalassemia Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Alpha Thalassemia Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Alpha Thalassemia Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Alpha Thalassemia Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Alpha Thalassemia Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Alpha Thalassemia Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Alpha Thalassemia Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Alpha Thalassemia Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Alpha Thalassemia Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Alpha Thalassemia Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Alpha Thalassemia Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Alpha Thalassemia Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Alpha Thalassemia Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Alpha Thalassemia Market Size by Country (2023-2028) & (US$ Million) Table 61. Bluebird Bio Company Details Table 62. Bluebird Bio Business Overview Table 63. Bluebird Bio Alpha Thalassemia Product Table 64. Bluebird Bio Revenue in Alpha Thalassemia Business (2017-2022) & (US$ Million) Table 65. Bluebird Bio Recent Developments Table 66. Novartis Company Details Table 67. Novartis Business Overview Table 68. Novartis Alpha Thalassemia Product Table 69. Novartis Revenue in Alpha Thalassemia Business (2017-2022) & (US$ Million) Table 70. Novartis Recent Developments Table 71. Kiadis Pharma Company Details Table 72. Kiadis Pharma Business Overview Table 73. Kiadis Pharma Alpha Thalassemia Product Table 74. Kiadis Pharma Revenue in Alpha Thalassemia Business (2017-2022) & (US$ Million) Table 75. Kiadis Pharma Recent Developments Table 76. Acceleron Pharma Company Details Table 77. Acceleron Pharma Business Overview Table 78. Acceleron Pharma Alpha Thalassemia Product Table 79. Acceleron Pharma Revenue in Alpha Thalassemia Business (2017-2022) & (US$ Million) Table 80. Acceleron Pharma Recent Developments Table 81. Research Programs/Design for This Report Table 82. Key Data Information from Secondary Sources Table 83. Key Data Information from Primary Sources List of Figures Figure 1. Global Alpha Thalassemia Market Share by Type: 2021 VS 2028 Figure 2. Iron Chelating Drugs Features Figure 3. Gene Therapy Features Figure 4. Global Alpha Thalassemia Market Share by Application: 2021 VS 2028 Figure 5. Hospitals Case Studies Figure 6. Private Clinics Case Studies Figure 7. Other Case Studies Figure 8. Alpha Thalassemia Report Years Considered Figure 9. Global Alpha Thalassemia Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Alpha Thalassemia Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Alpha Thalassemia Market Share by Region: 2021 VS 2028 Figure 12. Global Alpha Thalassemia Market Share by Players in 2021 Figure 13. Global Top Alpha Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Thalassemia as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Alpha Thalassemia Revenue in 2021 Figure 15. North America Alpha Thalassemia Market Size YoY (2017-2028) & (US$ Million) Figure 16. North America Alpha Thalassemia Market Size Market Share by Type (2017-2028) Figure 17. North America Alpha Thalassemia Market Size Market Share by Application (2017-2028) Figure 18. North America Alpha Thalassemia Market Size Share by Country (2017-2028) Figure 19. United States Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Alpha Thalassemia Market Size YoY (2017-2028) & (US$ Million) Figure 22. Europe Alpha Thalassemia Market Size Market Share by Type (2017-2028) Figure 23. Europe Alpha Thalassemia Market Size Market Share by Application (2017-2028) Figure 24. Europe Alpha Thalassemia Market Size Share by Country (2017-2028) Figure 25. Germany Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Alpha Thalassemia Market Size YoY (2017-2028) & (US$ Million) Figure 32. Asia Pacific Alpha Thalassemia Market Size Market Share by Type (2017-2028) Figure 33. Asia Pacific Alpha Thalassemia Market Size Market Share by Application (2017-2028) Figure 34. Asia Pacific Alpha Thalassemia Market Size Share by Region (2017-2028) Figure 35. China Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Japan Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. South Korea Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Southeast Asia Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. India Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Australia Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 41. Latin America Alpha Thalassemia Market Size YoY (2017-2028) & (US$ Million) Figure 42. Latin America Alpha Thalassemia Market Size Market Share by Type (2017-2028) Figure 43. Latin America Alpha Thalassemia Market Size Market Share by Application (2017-2028) Figure 44. Latin America Alpha Thalassemia Market Size Share by Country (2017-2028) Figure 45. Mexico Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Brazil Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Middle East & Africa Alpha Thalassemia Market Size YoY (2017-2028) & (US$ Million) Figure 48. Middle East and Africa Alpha Thalassemia Market Size Market Share by Type (2017-2028) Figure 49. Middle East and Africa Alpha Thalassemia Market Size Market Share by Application (2017-2028) Figure 50. Middle East and Africa Alpha Thalassemia Market Size Share by Country (2017-2028) Figure 51. Turkey Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. UAE Alpha Thalassemia Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Bluebird Bio Revenue Growth Rate in Alpha Thalassemia Business (2017-2022) Figure 55. Novartis Revenue Growth Rate in Alpha Thalassemia Business (2017-2022) Figure 56. Kiadis Pharma Revenue Growth Rate in Alpha Thalassemia Business (2017-2022) Figure 57. Acceleron Pharma Revenue Growth Rate in Alpha Thalassemia Business (2017-2022) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.